ArticleMedicine2026
Giant mucinous cystic neoplasm of the liver in a young asymptomatic woman: A case report.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
rationaleMucinous cystic neoplasm of the liver (MCN-L) is an uncommon cystic tumor with low malignant potential that mainly occurs in women. Because many patients have few or no symptoms and imaging findings may look similar to simple liver cysts or other cystic lesions, it is easy to make an incorrect diagnosis before surgery. PATIENT CONCERNS: A 36-year-old woman had no discomfort. A large cystic liver lesion was found by chance during a routine health checkup. She did not report abdominal pain, distension, fever, jaundice, or weight loss. DIAGNOSES: Imaging examinations showed a giant multilocular cystic mass about 20 cm in size in segment IV of the liver, with septal enhancement. Serum carbohydrate antigen 19-9 (CA19-9) was markedly increased (553 IU/mL), while other tests were unremarkable. MCN-L was suspected. Histopathology of the resected specimen confirmed a low-grade MCN-L with ovarian-type stroma, and immunohistochemistry showed estrogen and progesterone receptor positivity in the stromal cells.
interventionsBecause the tumor was very large and located close to major hepatic vessels, the patient underwent open segment IV hepatectomy. The whole cystic lesion was removed en bloc without rupture. OUTCOMES: The postoperative recovery was smooth, without bleeding, bile leakage, or infection. During 24 months of follow-up, abdominal computed tomography and serum CA19-9 were checked every 6 months. No tumor recurrence or metastasis was observed, and CA19-9 returned to the normal range. The patient's quality of life remained good. LESSONS: When a very large hepatic cystic lesion is identified in a young woman, especially with elevated CA19-9 and septal enhancement on magnetic resonance imaging, MCN-L should be considered in the differential diagnosis. Because preoperative diagnosis can be difficult, careful assessment of lesion size, internal architecture, and its relationship to major vessels is essential. Complete surgical resection with negative margins remains the preferred treatment, as it reduces the risks of recurrence and malignant transformation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.